DXCM vs PACS · P/E 63, rev $2.50B vs P/E 23, rev $5.29B
DexCom Inc (DXCM) versus PACS Group, Inc. (PACS) — a side-by-side from cached financials, not a winner call.
DexCom Inc (DXCM) is a medical devices company listed on US.
PACS Group, Inc. (PACS) is a medical care facilities company listed on NYSE.
Latest reported DXCM revenue for 2026-06-30 was $2.50B. Net income was $448.6M. DXCM currently screens at market cap $32.84B and trailing P/E 62.5.
Latest reported PACS revenue for 2025-12-31 was $5.29B. Net income was $191.5M. Revenue was up 29.3% from 2024-12-31 to 2025-12-31. PACS currently screens at market cap $5.58B and trailing P/E 22.7.
DXCM currently screens at market cap $32.84B and trailing P/E 62.5. PACS currently screens at market cap $5.58B and trailing P/E 22.7.
Not investment advice. Open the DXCM and PACS stock pages for the full models.
Not investment advice.